跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NGENLA 60 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NGENLA 60 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Approved
STANDARD
NGENLA 60 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Pfizer Europe Ma Eeig
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 16, 2022
Approval ID
d1f3480250518087
Company
Pfizer Europe Ma Eeig
Type
Standard
Approval Details
Approval Id
d1f3480250518087
Drug Cima Aemps Name
NGENLA 60 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number
1211617002
Holder Company Name
Pfizer Europe Ma Eeig
Marketing Company Name
Pfizer S.L.
Holder Company Detail Path
/organization/pfizer-europe-ma-eeig
Authorization Date
2022-03-16
Dosage Form
SOLUCIÓN INYECTABLE
Dose
60 mg /1,2ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Pfizer Europe Ma Eeig
Company Detail Path
/organization/pfizer-europe-ma-eeig
Company Information
Pharmaceutical Company Name
Pfizer Europe MA EEIG
Country Name
United Kingdom
Active Ingredients
SOMATROGON
60 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 16, 2022
Approval ID
d1f3480250518087
Type
Standard
Back to CIMA-AEMPS Approvals
